Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions

PURPOSE: Use of a combination corticosteroid/antibiotic product is common in ocular surface inflammatory conditions for which corticosteroid therapy is indicated and there exists a risk of superficial bacterial infection. Combination loteprednol etabonate 0.5% and tobramycin 0.3% (LE/T) has been eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Deom, James E, Kannarr, Shane, Vollmer, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677919/
https://www.ncbi.nlm.nih.gov/pubmed/36419563
http://dx.doi.org/10.2147/OPTH.S389688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677919/
https://www.ncbi.nlm.nih.gov/pubmed/36419563
http://dx.doi.org/10.2147/OPTH.S389688

Ejemplares similares